The acquisition of a drug portfolio is a significant development for Cosmos Health, indicating an aggressive growth strategy. This could lead to increased investor confidence and a positive short-term impact on COSM's stock price, as the market often reacts favorably to expansion moves that promise to enhance a company's product offerings and competitive edge.